Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
Aly‐Khan A. Lalani(Juravinski Cancer Centre), Toni K. Choueiri(Harvard University), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Dylan J. Martini(Dana-Farber Cancer Institute), John A. Steinharter(Memorial Sloan Kettering Cancer Center), Chad J. Creighton(Baylor College of Medicine), Audrey Duquette(Dana-Farber Cancer Institute), Lauren C. Harshman(Dana-Farber Cancer Institute), Bradley A. McGregor(Harvard University), Wanling Xie(Dana-Farber Cancer Institute), Joaquim Bellmunt(Dana-Farber Cancer Institute), Katherine M. Krajewski(Brigham and Women's Hospital), Craig Norton(Dana-Farber Cancer Institute), Dominick Bossé(Dana-Farber Cancer Institute)
Cited by 267
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k